Aragen setting up a US$ 30 million bio-manufacturing site in Bengaluru
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Good momentum in commercial CDMO business
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
Subscribe To Our Newsletter & Stay Updated